Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A rare, aggressive variant of intrahepatic cholangiocarcinoma. It is characterized by the presence of adenocarcinoma cells that are intermingled with malignant pleomorphic spindle cells.
No clinical trials have been registered for sarcomatous intrahepatic cholangiocarcinoma.
4 publications have been identified in PubMed for sarcomatous intrahepatic cholangiocarcinoma. Research spans Case Report / Case Series (75%) and Review / Meta-Analysis (25%).
Ji X (2026). [PMID: 42040540](https://pubmed.ncbi.nlm.nih.gov/42040540/). *Front Med (Lausanne)*. [Case Report / Case Series]
Tsai TC (2025). [PMID: 39931030](https://pubmed.ncbi.nlm.nih.gov/39931030/). *Journal of surgical case reports*. [Case Report / Case Series]
Nguyen QT (2025). [PMID: 39375230](https://pubmed.ncbi.nlm.nih.gov/39375230/). *Medical molecular morphology*. [Review / Meta-Analysis]
Shimoda T (2024). [PMID: 40786016](https://pubmed.ncbi.nlm.nih.gov/40786016/). *ACG case reports journal*. [Case Report / Case Series]
Data assembled from 2 of 12 sources · Last updated Sep 19, 2026, 6:58 PM UTC
AI-curated news mentioning sarcomatous intrahepatic cholangiocarcinoma
Updated Aug 28, 2026
A case study highlights the cholangioblastic variant of intrahepatic cholangiocarcinoma in a young adult with situs inversus totalis. This discovery adds to the understanding of rare cancer presentations and their potential associations.
A recent study investigates whether the surgical approach impacts benchmark attainment in intrahepatic cholangiocarcinoma. Findings suggest that surgical techniques may play a significant role in patient outcomes.
A recent study highlights the incidental detection of intrahepatic cholangiocarcinoma in patients who underwent living-donor liver transplantation for polycystic liver disease. This finding underscores the need for careful post-transplant monitoring in this patient population.